MENTOR RESPONDS TO REQUEST FOR IMPLANT MORATORUIUM
MENTOR RESPONDS TO REQUEST FOR IMPLANT MORATORUIUM SANTA BARBARA, Calif., Jan. 6 /PRNewswire/ -- Mentor Corp.
(NASDAQ: MNTR) announced today that in a press conference held today, Food and Drug Administration Commissioner David Kessler requested a voluntary moratorium on the use of silicone-gel breast implants until new safety data can be reviewed by an FDA advisory panel. In response to the FDA press conference, Christopher J. Conway, chairman of Mentor Corp., stated: "We are perplexed and confused at this action of the FDA. The only new safety data relating to Mentor's products that we are aware of supports the safety of our products, as does all the scientific data we know of. If the FDA has data which it has not shared with the manufacturers and the public, we request that such data be made available to the public immediately, in order that other responsible scientists may evaluate it.
"We intend to comply temporarily with the FDA's request for a moratorium while we await clarification of the basis for the request and evaluate whatever new data the FDA makes available regarding Mentor products. "Meanwhile, as the leading producer of saline-filled implants, which are not affected by the moratorium, we will continue to try to meet the public's need for breast implants." U.S. sales of silicone-gel breast implants accounted for about $11 million, or 15 percent, of Mentor's sales last year. Mentor Corp. produces medical and surgical devices for the specialties of urology, plastic surgery and ophthalmology. -0- 1/6/92 /CONTACT: Christopher J. Conway, chairman of Mentor, 805-681-6000/ (MNTR) CO: Mentor Corp. ST: California IN: MTC SU:
KJ-EH -- LA026 -- 7046 01/06/92 16:39 EST
|Printer friendly Cite/link Email Feedback|
|Date:||Jan 6, 1992|
|Previous Article:||SPIEGEL TO CLOSE ITS 17 HONEYBEE STORES|
|Next Article:||AIRSHIP SHAMU TAKES MARINE ANIMAL RESEARCH TO GREAT HEIGHTS|